113 related articles for article (PubMed ID: 36838857)
21. Repurposing of the ALK Inhibitor Crizotinib for Acute Leukemia and Multiple Myeloma Cells.
Boulos JC; Saeed MEM; Chatterjee M; Bülbül Y; Crudo F; Marko D; Munder M; Klauck SM; Efferth T
Pharmaceuticals (Basel); 2021 Nov; 14(11):. PubMed ID: 34832908
[TBL] [Abstract][Full Text] [Related]
22. Emergence of Cardiac Glycosides as Potential Drugs: Current and Future Scope for Cancer Therapeutics.
Kumavath R; Paul S; Pavithran H; Paul MK; Ghosh P; Barh D; Azevedo V
Biomolecules; 2021 Aug; 11(9):. PubMed ID: 34572488
[TBL] [Abstract][Full Text] [Related]
23. Catharanthus roseus (L.) G. Don: A review of its ethnobotany, phytochemistry, ethnopharmacology and toxicities.
Kumar S; Singh B; Singh R
J Ethnopharmacol; 2022 Feb; 284():114647. PubMed ID: 34562562
[TBL] [Abstract][Full Text] [Related]
24. Network pharmacology of triptolide in cancer cells: implications for transcription factor binding.
Seo EJ; Dawood M; Hult AK; Olsson ML; Efferth T
Invest New Drugs; 2021 Dec; 39(6):1523-1537. PubMed ID: 34213719
[TBL] [Abstract][Full Text] [Related]
25. A Compressive Review about Taxol
Gallego-Jara J; Lozano-Terol G; Sola-Martínez RA; Cánovas-Díaz M; de Diego Puente T
Molecules; 2020 Dec; 25(24):. PubMed ID: 33348838
[TBL] [Abstract][Full Text] [Related]
26. 2α-Hydroxyalantolactone from Pulicaria undulata: activity against multidrug-resistant tumor cells and modes of action.
Hegazy MF; Dawood M; Mahmoud N; Elbadawi M; Sugimoto Y; Klauck SM; Mohamed N; Efferth T
Phytomedicine; 2021 Jan; 81():153409. PubMed ID: 33341310
[TBL] [Abstract][Full Text] [Related]
27. Cytotoxicity of apigenin toward multiple myeloma cell lines and suppression of iNOS and COX-2 expression in STAT1-transfected HEK293 cells.
Adham AN; Abdelfatah S; Naqishbandi AM; Mahmoud N; Efferth T
Phytomedicine; 2021 Jan; 80():153371. PubMed ID: 33070080
[TBL] [Abstract][Full Text] [Related]
28. Prospects and Therapeutic Applications of Cardiac Glycosides in Cancer Remediation.
Ayogu JI; Odoh AS
ACS Comb Sci; 2020 Nov; 22(11):543-553. PubMed ID: 32786321
[TBL] [Abstract][Full Text] [Related]
29. Leaf Extract of
Mohapatra S; Biswal AK; Dandapat J; Debata PR
Anticancer Agents Med Chem; 2021; 21(5):649-657. PubMed ID: 32781975
[TBL] [Abstract][Full Text] [Related]
30. Cytotoxic bufadienolides from the leaves of a medicinal plant Melianthus comosus collected in South Africa.
Bedane KG; Brieger L; Strohmann C; Seo EJ; Efferth T; Spiteller M
Bioorg Chem; 2020 Sep; 102():104102. PubMed ID: 32721779
[TBL] [Abstract][Full Text] [Related]
31. Chemometric and Transcriptomic Profiling, Microtubule Disruption and Cell Death Induction by Secalonic Acid in Tumor Cells.
Özenver N; Dawood M; Fleischer E; Klinger A; Efferth T
Molecules; 2020 Jul; 25(14):. PubMed ID: 32679716
[TBL] [Abstract][Full Text] [Related]
32. Tumor microenvironment and epithelial mesenchymal transition as targets to overcome tumor multidrug resistance.
Erin N; Grahovac J; Brozovic A; Efferth T
Drug Resist Updat; 2020 Dec; 53():100715. PubMed ID: 32679188
[TBL] [Abstract][Full Text] [Related]
33. Cytotoxic Bufadienolides from the Leaves of
Bedane KG; Brieger L; Strohmann C; Seo EJ; Efferth T; Spiteller M
J Nat Prod; 2020 Jul; 83(7):2122-2128. PubMed ID: 32663024
[No Abstract] [Full Text] [Related]
34. Toxicity effects of
Farkhondeh T; Kianmehr M; Kazemi T; Samarghandian S; Khazdair MR
Hum Exp Toxicol; 2020 Jun; 39(6):773-784. PubMed ID: 31971021
[TBL] [Abstract][Full Text] [Related]
35. Review: Quality of herbal medicinal products: State of the art of purity assessment.
Steinhoff B
Phytomedicine; 2019 Jul; 60():153003. PubMed ID: 31327654
[TBL] [Abstract][Full Text] [Related]
36. Nerigoside suppresses colorectal cancer cell growth and metastatic potential through inhibition of ERK/GSK3β/β-catenin signaling pathway.
Wen SY; Chen YY; Deng CM; Zhang CQ; Jiang MM
Phytomedicine; 2019 Apr; 57():352-363. PubMed ID: 30831484
[TBL] [Abstract][Full Text] [Related]
37. Cardenolides: Insights from chemical structure and pharmacological utility.
El-Seedi HR; Khalifa SAM; Taher EA; Farag MA; Saeed A; Gamal M; Hegazy MF; Youssef D; Musharraf SG; Alajlani MM; Xiao J; Efferth T
Pharmacol Res; 2019 Mar; 141():123-175. PubMed ID: 30579976
[TBL] [Abstract][Full Text] [Related]
38. A review of cardiac glycosides: Structure, toxicokinetics, clinical signs, diagnosis and antineoplastic potential.
Botelho AFM; Pierezan F; Soto-Blanco B; Melo MM
Toxicon; 2019 Feb; 158():63-68. PubMed ID: 30529380
[TBL] [Abstract][Full Text] [Related]
39. Oleandrin and Its Derivative Odoroside A, Both Cardiac Glycosides, Exhibit Anticancer Effects by Inhibiting Invasion via Suppressing the STAT-3 Signaling Pathway.
Ko YS; Rugira T; Jin H; Park SW; Kim HJ
Int J Mol Sci; 2018 Oct; 19(11):. PubMed ID: 30373171
[TBL] [Abstract][Full Text] [Related]
40. Oleandrin synergizes with cisplatin in human osteosarcoma cells by enhancing cell apoptosis through activation of the p38 MAPK signaling pathway.
Yong L; Ma Y; Zhu B; Liu X; Wang P; Liang C; He G; Zhao Z; Liu Z; Liu X
Cancer Chemother Pharmacol; 2018 Dec; 82(6):1009-1020. PubMed ID: 30267330
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
